Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating VSV-IFNβ-NIS in combination with ipilimumab and nivolumab for advanced or metastatic clear cell renal cell carcin…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 randomized trial evaluating the combination of fianlimab and cemiplimab with or without ipilimumab, or ipilimumab plus nivolumab, …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
A USC-sponsored clinical trial evaluates a myeloid-derived suppressor cell assay in renal cell carcinoma; the study is active but not recrui…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) [Phase 1]
A Phase 1b trial (SHARK) evaluating HC-7366, an ISR agonist, in kidney cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults
This clinical trial update describes a study evaluating the effectiveness of cabozantinib in combination with nivolumab as first-line treatm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC [Phase 3]
Phase 3 study to assess safety and efficacy of 177Lu-TLX250 in advanced relapsed or recurrent clear cell renal cell carcinoma is currently r…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer
This ClinicalTrials.gov study is recruiting to explore patient-partnered research on Fear of Cancer Recurrence in individuals with Renal Cel…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
An observational real-world study assessing cabozantinib as monotherapy or in combination with nivolumab for advanced or metastatic renal ce…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating Pumitamig alone or in combination with ipilimumab or cabozantinib in adults with advanced renal cel…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
An NCI-sponsored clinical trial evaluating Von Hippel-Lindau–associated renal and other urologic malignancies, including manifestations, dia…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma [NA]
Clinical trial update for a metastatic renal cell carcinoma study evaluating a fasting-mimicking diet in combination with IO-TKI therapy; th…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations [Phase 2]
A Phase 2 clinical trial evaluating olaparib in metastatic renal cell carcinoma patients with DNA repair gene mutations is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue [NA]
A Memorial Sloan Kettering Cancer Center trial evaluating radiation therapy for solid tumors that have metastasized to soft tissue. The stud…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy [NA]
Clinical trial investigating ischemic preconditioning to reduce acute kidney injury after partial nephrectomy; the study is currently not ye…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors [Phase 1, Phase 2]
A Phase Ib/II trial is evaluating the combination of Envafolimab (PD-L1 inhibitor) and lenvatinib in patients with solid tumors, including n…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for a combination of sasanlimab, palbociclib, and axitinib in metastatic renal cell carcinoma; currently recru…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma [EARLY_Phase 1]
This document reports an ongoing early-phase neoadjuvant trial of pembrolizumab and lenvatinib for renal cell carcinoma, with patient recrui…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer [NA]
A clinical trial evaluating an app-based mindfulness intervention to improve quality of life in patients with metastatic renal cell carcinom…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma [Phase 2]
This Phase 2 clinical trial update describes evaluating SBRT in combination with anlotinib and bimepolizumab for locally advanced or metasta…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study [Phase 2]
Phase II clinical trial evaluating AK112 (Yiwoxidan Anti) as monotherapy for metastatic clear cell renal cell carcinoma in patients intolera…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Drug Screening Using Novel IMD in Renal Cell Carcinoma [Phase 1]
This update notes an ongoing Phase 1 trial evaluating a novel investigational drug (Novel IMD) for renal cell carcinoma, with enrollment by …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC [Phase 2]
ClinicalTrials.gov update describes a Phase 2 neoadjuvant trial (NEOSHIFT-RCC) evaluating HIF-inhibitor immunotherapy for renal cell carcino…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers [NA]
A clinical trial update describing MRI functional imaging characteristics and fat quantification of CT-fat-free renal neoplasms and their re…